4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide
C40H46F2N12O4 — CID 159569353
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide
4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide (PubChem CID 159569353) has the molecular formula C40H46F2N12O4 and a molecular weight of 796.88 g/mol. Its IUPAC name is 4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide.
Molecular Properties
| Compound Name | 4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide |
|---|---|
| PubChem CID | 159569353 |
| Molecular Formula | C40H46F2N12O4 |
| Molecular Weight | 796.88 g/mol |
| Exact Mass | 796.37 |
| IUPAC Name | 4-(8-cyanoquinoxalin-5-yl)-N-[[(3R)-3-fluoropyrrolidin-3-yl]methyl]-6-methylmorpholine-2-carboxamide |
| SMILES | CC1CN(c2ccc(C#N)c3nccnc23)CC(C(=O)NC[C@@]2(F)CCNC2)O1.CC1CN(c2ccc(C#N)c3nccnc23)CC(C(=O)NC[C@@]2(F)CCNC2)O1 |
| InChI | InChI=1S/2C20H23FN6O2/c2*1-13-9-27(15-3-2-14(8-22)17-18(15)25-7-6-24-17)10-16(29-13)19(28)26-12-20(21)4-5-23-11-20/h2*2-3,6-7,13,16,23H,4-5,9-12H2,1H3,(H,26,28)/t2*13?,16?,20-/m11/s1 |
| InChIKey | MHPRAYBKZXULDU-AXVYIYKUSA-N |
| XLogP | 1.83 |
| TPSA | 206.34 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 796.88 |
| LogP ≤ 5 | 1.83 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159569353 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.